Share chart Corcept Therapeutics Incorporated
Extended chart
Simple chart
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated открывает, разрабатывает и продает лекарства для лечения тяжелых метаболических, онкологических и психических расстройств в США. Компания предлагает таблетки Корлим (мифепристон) в качестве перорального препарата один раз в день для лечения гипергликемии, вторичной по отношению к гиперкортизолизму, у взрослых пациентов с эндогенным синдромом Кушинга, страдающих сахарным диабетом 2 типа или непереносимостью глюкозы, которые не прошли операцию или не являются кандидатами на лечение. операция. more detailsIPO date | 2004-04-14 |
---|---|
ISIN | US2183521028 |
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.corcept.com |
Цена ао | 55 |
Change price per week: | +1.29% (54.3) |
---|---|
Change price per month: | -19.25% (68.11) |
Change price per 3 month: | -2.35% (56.325) |
Change price per half year: | +44.32% (38.11) |
Change price per year: | +132.36% (23.67) |
Change price per 3 year: | +115.18% (25.56) |
Change price per 5 year: | +195.06% (18.64) |
Change price per 10 year: | +1 024.74% (4.89) |
Change price per year to date: | +8.06% (50.9) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Blackrock Inc. | 16407696 | 15.85 |
Vanguard Group Inc | 9537532 | 9.21 |
Ingalls & Snyder | 8351827 | 8.07 |
Renaissance Technologies, LLC | 6725871 | 6.5 |
Parallel Advisors, LLC | 3768245 | 3.64 |
State Street Corporation | 3387465 | 3.27 |
Novo Holdings A/S | 2411362 | 2.33 |
Dimensional Fund Advisors LP | 2310297 | 2.23 |
Geode Capital Management, LLC | 2045646 | 1.98 |
Boston Trust Walden Corporation | 1846924 | 1.78 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Sean Maduck | President of Endocrinology | 823.42k | 1977 (48 years) |
Mr. Gary Charles Robb | Chief Business Officer & Secretary | 963k | 1963 (62 years) |
Mr. Atabak Mokari | CFO & Treasurer | 760.75k | 1977 (48 years) |
Mr. Joseph Douglas Lyon | Chief Accounting & Technology Officer | N/A | 1978 (47 years) |
Ms. Amy Flood | Chief Human Resources & Communications Officer | N/A | |
Dr. William Guyer Pharm.D. | Chief Development Officer | N/A | 1968 (57 years) |
Dr. Hazel Hunt Ph.D. | Chief Scientific Officer | 895.16k | 1960 (65 years) |
Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director | 1.82M | 1957 (68 years) |
Ms. Monica Tellado | President of Emerging Markets | N/A | 1973 (52 years) |
Mr. Roberto W. Vieira | President of Oncology | N/A |
Address: United States, Menlo Park, CA , 149 Commonwealth Drive - open in Google maps, open in Yandex maps
Website: http://www.corcept.com
Website: http://www.corcept.com